You just read:

BerGenBio Enters Collaboration With MSD Focused on Clinical Evaluation of BGB324 in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Lung and Breast Cancer

News provided by

BerGenBio ASA

08 Mar, 2017, 07:04 ET